References
- Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003, 258, 141–151.
- Cosco D, Celia C, Cilurzo F, Trapasso E, Paolino D. Colloidal carriers for the enhanced delivery through the skin. Expert Opin Drug Deliv 2008, 5, 737–755.
- Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000, 65, 403–418.
- Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004, 278, 1–23.
- Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009, 366, 170–184.
- de Leeuw J, de Vijlder HC, Bjerring P, Neumann HA. Liposomes in dermatology today. J Eur Acad Dermatol Venereol 2009, 23, 505–516.
- Horwitz E, Pisanty S, Czerninski R, Helser M, Eliav E, Touitou E. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 87, 700–705.
- Jain S, Umamaheshwari R, Bhadra D, Jain N. Ethosomes: a novel vesicular carries for enhanced transdermal delivery of an anti HIV agent. Indian J Pharm Sci 2004, 66, 72–81.
- Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000, 21, 1879–1885.
- Godin B, Touitou E, Rubinstein E, Athamna A, Athamna M. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J Antimicrob Chemother 2005, 55, 989–994.
- Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials 2001, 22, 3053–3059.
- Kaplun-Frischoff Y, Touitou E. Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J Pharm Sci 1997, 86, 1394–1399.
- Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release 2004, 94, 365–379.
- de Leeuw J, van der Beek N, Bjerring P, Neumann HA. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents. J Eur Acad Dermatol Venereol 2010, 24, 460–469.
- Clemmensen A, Thormann J, Andersen KE. Allergic contact dermatitis from retinyl palmitate in polycaprolactone. Contact Derm 2007, 56, 288–289.
- Marston S. Propyl gallate on liposomes. Contact Derm 1992, 27, 74–76.
- Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004, 21, 1818–1825.
- Madsen JT, Vogel S, Karlberg AT, Simonsson C, Johansen JD, Andersen KE. Ethosome formulations of known contact allergens can increase their sensitizing capacity. Acta Derm Venereol 2010, 90, 374–378.
- Madsen JT, Vogel S, Karlberg AT, Simonsson C, Johansen JD, Andersen KE. Ethosome formulation of contact allergens may enhance patch test reactions in patients. Contact Derm 2010, 63, 209–214.
- Madsen JT, Andersen KE. Microvesicle formulations used in topical drugs and cosmetics affect product efficiency, performance and allergenicity. Dermatitis 2010, 21, 243–247.
- Walde P, Ichikawa S. Enzymes inside lipid vesicles: preparation, reactivity and applications. Biomol Eng 2001, 18, 143–177.
- Molpeceres J, Guzman M, Aberturas MR, Chacon M, Berges L. Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement. J Pharm Sci 1996, 85, 206–213.
- Heeremans JL, Gerritsen HR, Meusen SP, Mijnheer FW, Gangaram Panday RS, Prevost R, Kluft C, Crommelin DJ. The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target 1995, 3, 301–310.
- OECD. Organisation for Economic Co-operation and Development (OECD). Guideline for the Testing of Chemicals: (Part 429), 2002.
- Andersen KE, Carlsen L, Egsgaard H, Larsen E. Contact sensitivity and bioavailability of chlorocresol. Contact Derm 1985, 13, 246–251.
- McGarry HF. The murine local lymph node assay: regulatory and potency considerations under REACH. Toxicology 2007, 238, 71–89.
- Jowsey IR, Clapp CJ, Safford B, Gibbons BT, Basketter DA. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay. Cutan Ocul Toxicol 2008, 27, 67–75.
- Basketter DA, Gerberick GF, Kimber I. Skin sensitisation, vehicle effects and the local lymph node assay. Food Chem Toxicol 2001, 39, 621–627.
- Jiménez MM, Pelletier J, Bobin MF, Martini MC. Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate. Int J Pharm 2004, 272, 45–55.
- Wright ZM, Basketter PA, Blaikie L, Cooper KJ, Warbrick EV, Dearman RJ, Kimber I. Vehicle effects on skin sensitizing potency of four chemicals: assessment using the local lymph node assay. Int J Cosmet Sci 2001, 23, 75–83.
- Ryan CA, Cruse LW, Skinner RA, Dearman RJ, Kimber I, Gerberick GF. Examination of a vehicle for use with water soluble materials in the murine local lymph node assay. Food Chem Toxicol 2002, 40, 1719–1725.
- Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 2002, 54(Suppl. 1), S41–S55.